Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
Ionis Pharmaceuticals, Inc.
Brian A Bergmark; Nicholas A Marston; Thomas A Prohaska; Veronica J Alexander; André Zimerman; Filipe A Moura; Sabina A Murphy; Erica L Goodrich; Shuanglu Zhang; Daniel Gaudet; Ewa Karwatowska-Prokopczuk; Sotirios Tsimikas; Robert P Giugliano; Marc S Sabatine; Bridge–TIMI 73a Investigators